These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9081205

  • 21. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E.
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [Abstract] [Full Text] [Related]

  • 22. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group.
    Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
    [Abstract] [Full Text] [Related]

  • 23. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, Rajkumar SV.
    Curr Hematol Malig Rep; 2010 Apr; 5(2):62-9. PubMed ID: 20425398
    [Abstract] [Full Text] [Related]

  • 24. Monoclonal gammopathy of undetermined significance.
    Kyle RA, Rajkumar SV.
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [Abstract] [Full Text] [Related]

  • 25.
    Kaseb H, Annamaraju P, Babiker HM.
    ; 2024 01. PubMed ID: 29939657
    [Abstract] [Full Text] [Related]

  • 26. [A long-term observation of development from monoclonal gammopathy of undetermined significance (MGUS) into primary amyloidosis].
    Kanoh T, Yago K, Okuma M.
    Rinsho Ketsueki; 1990 Oct; 31(10):1740-4. PubMed ID: 2255066
    [Abstract] [Full Text] [Related]

  • 27. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K.
    Klin Onkol; 2018 Oct; 31(4):270-276. PubMed ID: 30541309
    [Abstract] [Full Text] [Related]

  • 28. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.
    Rajkumar SV, Dispenzieri A, Kyle RA.
    Mayo Clin Proc; 2006 May; 81(5):693-703. PubMed ID: 16706268
    [Abstract] [Full Text] [Related]

  • 29. IgD monoclonal gammopathy of undetermined significance.
    Kinoshita T, Nagai H, Murate T, Saito H, Fukatsu T, Hotta T.
    Int J Hematol; 1997 Feb; 65(2):169-72. PubMed ID: 9071822
    [Abstract] [Full Text] [Related]

  • 30. Monoclonal gammopathy and multiple myeloma in the elderly.
    Kyle RA.
    Baillieres Clin Haematol; 1987 Jun; 1(2):533-57. PubMed ID: 3322448
    [Abstract] [Full Text] [Related]

  • 31. Up-date on solitary plasmacytoma and its main differences with multiple myeloma.
    Di Micco P, Di Micco B.
    Exp Oncol; 2005 Mar; 27(1):7-12. PubMed ID: 15812350
    [Abstract] [Full Text] [Related]

  • 32. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
    Pasqualetti P, Casale R.
    Biomed Pharmacother; 1997 Mar; 51(2):74-8. PubMed ID: 9161471
    [Abstract] [Full Text] [Related]

  • 33. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA, Rajkumar SV.
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [Abstract] [Full Text] [Related]

  • 34. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ.
    Blood; 2003 Nov 15; 102(10):3759-64. PubMed ID: 12881316
    [Abstract] [Full Text] [Related]

  • 35. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E.
    J Clin Oncol; 2002 Mar 15; 20(6):1625-34. PubMed ID: 11896113
    [Abstract] [Full Text] [Related]

  • 36. [Benign monoclonal gammopathy].
    Shirota T, Kondo M, Uchida H, Ito H.
    Nihon Rinsho; 1995 Mar 15; 53(3):720-4. PubMed ID: 7699912
    [Abstract] [Full Text] [Related]

  • 37. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, Rajkumar SV.
    N Engl J Med; 2018 Jan 18; 378(3):241-249. PubMed ID: 29342381
    [Abstract] [Full Text] [Related]

  • 38. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases.
    Kyle RA.
    Am J Med; 1978 May 18; 64(5):814-26. PubMed ID: 645746
    [Abstract] [Full Text] [Related]

  • 39. [Expression of microRNA-221/222 in patients with monoclonal gammopathy of undetermined significance and multiple myeloma].
    Yang S, Wang W, Jin H, Zhong Y, Xie X.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May 25; 45(4):371-378. PubMed ID: 27868410
    [Abstract] [Full Text] [Related]

  • 40. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR.
    Clin Cancer Res; 2002 Jul 25; 8(7):2210-6. PubMed ID: 12114422
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.